RenovoRx, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
On November 10, 2025, our company and each of our executive officers (namely Shaun Bagai, Ramtin Agah, Ronald Kocak and Leesa Gentry) entered into Amended and Restated Change of Control and Severance Agreements (the “Amended CoC Agreements”). The Amended CoC Agreements (which were approved by the Compensation Committee of our Board of Directors) amend the existing Change of Control and Severance Agreements with such executives with the effect of (i) adding the payment of a pro-rated bonus if there is a termination during the Change in Control Period (as defined in the Amended CoC Agreements) and (b) increasing the Change in Control Period from one year to two years. The Amended CoC Agreements are filed as Exhibits 10.1, 10.2, 10.3 and 10.4, respectively, to this Report. The foregoing description of the Amended CoC Agreements is qualified in its entirety to the full text of such exhibits, which text is incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.